This blog links to patient friendly commentary about current HCV treatment options, using information extracted from news articles, peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
1Department of Infectious Diseases, University Hospital Crosshouse, Kilmarnock, Scotland.
In the era of efficacious and well-tolerated treatment for chronic hepatitis C virus (HCV) infection, there is an expanding population of individuals who achieve viral eradication. This in turn has generated a need to determine the impact of liver-related morbidity and mortality, particularly liver decompensation and hepatocellular carcinoma, in populations achieving sustained viral response (SVR), and how they correlate with that of the general population. |Full Article in PDF|